Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
暂无分享,去创建一个
Erwin G. Van Meir | D. Brat | J. Olson | D. Durden | N. Mackman | V. Belozerov | C. Tucker-Burden | Y. Rong | Gang Chen
[1] Michael Karin,et al. NF-kappaB and cancer-identifying targets and mechanisms. , 2008, Current opinion in genetics & development.
[2] D. Brat,et al. RESEARCH ARTICLE: Intravascular Thrombosis in Central Nervous System Malignancies: A Potential Role in Astrocytoma Progression to Glioblastoma , 2007, Brain pathology.
[3] Zhiwei Hu,et al. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. , 2007, Blood.
[4] Hong Wu,et al. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. , 2007, Cancer cell.
[5] P. Vogt,et al. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth , 2007, Oncogene.
[6] Wei Chen,et al. Differential regulation and properties of MAPKs , 2007, Oncogene.
[7] Yuri Kotliarov,et al. High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. , 2006, Cancer research.
[8] Erwin G. Van Meir,et al. Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. , 2006, Cancer research.
[9] Daniel J Brat,et al. 'Pseudopalisading' Necrosis in Glioblastoma: A Familiar Morphologic Feature That Links Vascular Pathology, Hypoxia, and Angiogenesis , 2006, Journal of neuropathology and experimental neurology.
[10] Jayant P. Menon,et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.
[11] A. Maity,et al. EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms. , 2006, Cancer research.
[12] Koji Yoshimoto,et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. , 2005, The New England journal of medicine.
[13] Dejan Juric,et al. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. , 2005, Cancer research.
[14] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[15] Erwin G. Van Meir,et al. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. , 2005, Cancer research.
[16] S. Shirasawa,et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. , 2005, Blood.
[17] Yan Liu,et al. Human Bcl-2 activates ERK signaling pathway to regulate activating protein-1, lens epithelium-derived growth factor and downstream genes , 2004, Oncogene.
[18] P. Carmeliet,et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling , 2004, Nature Medicine.
[19] Daniel J Brat,et al. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma , 2004, Laboratory Investigation.
[20] Daniel J Brat,et al. Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population , 2004, Cancer Research.
[21] L. Cantley,et al. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.
[22] Mehdi Tnani,et al. Elevated JNK activation contributes to the pathogenesis of human brain tumors , 2002, Oncogene.
[23] P. Libby,et al. Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor κB, and Egr-1* , 2002, The Journal of Biological Chemistry.
[24] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[25] M. Karin,et al. AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.
[26] David Baltimore,et al. Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.
[27] A. Falanga,et al. Molecular basis for the relationship between thrombosis and cancer. , 2001, Thrombosis research.
[28] P. Carmeliet,et al. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Kyriakis,et al. Signaling by the Germinal Center Kinase Family of Protein Kinases* , 1999, The Journal of Biological Chemistry.
[30] D. Louis,et al. PTEN mutations in gliomas and glioneuronal tumors , 1998, Oncogene.
[31] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[32] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[33] J. Kuratsu,et al. Expression of tissue factor correlates with grade of malignancy in human glioma , 1996, Cancer.
[34] G. Hair,et al. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease , 1996, Nature Medicine.
[35] S. Tebbutt,et al. Extrinsic-pathway activation in cancer with high factor Vlla and tissue factor , 1995, The Lancet.
[36] N. Mackman. Regulation of the tissue factor gene , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] W. Cavenee,et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] K. Kinzler,et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[39] S B Green,et al. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme , 1987, Cancer.
[40] M. Karin,et al. NF- κ B and Cancer — Identifying Targets and Mechanisms , 2008 .